Literature DB >> 28874848

Suppressive drug combinations and their potential to combat antibiotic resistance.

Nina Singh1, Pamela J Yeh1.   

Abstract

Antibiotic effectiveness often changes when two or more such drugs are administered simultaneously and unearthing antibiotic combinations with enhanced efficacy (synergy) has been a longstanding clinical goal. However, antibiotic resistance, which undermines individual drugs, threatens such combined treatments. Remarkably, it has emerged that antibiotic combinations whose combined effect is lower than that of at least one of the individual drugs can slow or even reverse the evolution of resistance. We synthesize and review studies of such so-called 'suppressive interactions' in the literature. We examine why these interactions have been largely disregarded in the past, the strategies used to identify them, their mechanistic basis, demonstrations of their potential to reverse the evolution of resistance and arguments for and against using them in clinical treatment. We suggest future directions for research on these interactions, aiming to expand the basic body of knowledge on suppression and to determine the applicability of suppressive interactions in the clinic.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28874848      PMCID: PMC5659931          DOI: 10.1038/ja.2017.102

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  98 in total

1.  Recombination in HIV and the evolution of drug resistance: for better or for worse?

Authors:  Michael T Bretscher; Christian L Althaus; Viktor Müller; Sebastian Bonhoeffer
Journal:  Bioessays       Date:  2004-02       Impact factor: 4.345

2.  Bacterial persistence as a phenotypic switch.

Authors:  Nathalie Q Balaban; Jack Merrin; Remy Chait; Lukasz Kowalik; Stanislas Leibler
Journal:  Science       Date:  2004-08-12       Impact factor: 47.728

Review 3.  Can landscape ecology untangle the complexity of antibiotic resistance?

Authors:  Randall S Singer; Michael P Ward; George Maldonado
Journal:  Nat Rev Microbiol       Date:  2006-12       Impact factor: 60.633

4.  Combination drugs, an emerging option for antibacterial therapy.

Authors:  Guillaume Cottarel; Jamey Wierzbowski
Journal:  Trends Biotechnol       Date:  2007-11-08       Impact factor: 19.536

5.  Functional classification of drugs by properties of their pairwise interactions.

Authors:  Pamela Yeh; Ariane I Tschumi; Roy Kishony
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

6.  The bacteria fight back.

Authors:  Gary Taubes
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

7.  Resource competition and within-host disease dynamics.

Authors:  V H Smith; R D Holt
Journal:  Trends Ecol Evol       Date:  1996-09       Impact factor: 17.712

8.  Pairwise antibiotic interactions in Escherichia coli: triclosan, rifampicin and aztreonam with nine other classes of antibiotics.

Authors:  Caroline Nguyen; Alice Zhou; Ayesha Khan; Jeffrey H Miller; Pamela Yeh
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

Review 9.  Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research.

Authors:  B H Ali
Journal:  Food Chem Toxicol       Date:  2003-11       Impact factor: 6.023

10.  When more is less: Emergent suppressive interactions in three-drug combinations.

Authors:  Casey Beppler; Elif Tekin; Cynthia White; Zhiyuan Mao; Jeffrey H Miller; Robert Damoiseaux; Van M Savage; Pamela J Yeh
Journal:  BMC Microbiol       Date:  2017-05-06       Impact factor: 3.605

View more
  19 in total

1.  Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.

Authors:  John T Williams; Elizabeth R Haiderer; Garry B Coulson; Kayla N Conner; Edmund Ellsworth; Chao Chen; Nadine Alvarez-Cabrera; Wei Li; Mary Jackson; Thomas Dick; Robert B Abramovitch
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

2.  Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer.

Authors:  Shruti Choudhary; Arpit Doshi; Lerin Luckett-Chastain; Michael Ihnat; Ernest Hamel; Susan L Mooberry; Aleem Gangjee
Journal:  Bioorg Med Chem       Date:  2021-02-12       Impact factor: 3.641

3.  Fighting microbial pathogens by integrating host ecosystem interactions and evolution.

Authors:  Alita R Burmeister; Elsa Hansen; Jessica J Cunningham; E Hesper Rego; Paul E Turner; Joshua S Weitz; Michael E Hochberg
Journal:  Bioessays       Date:  2020-12-30       Impact factor: 4.653

4.  Known Antimicrobials Versus Nortriptyline in Candida albicans: Repositioning an Old Drug for New Targets.

Authors:  Marina Caldara; Nelson Marmiroli
Journal:  Microorganisms       Date:  2020-05-15

5.  Emodin Reduces the Activity of (1,3)-β-D-glucan Synthase from Candida albicans and Does Not Interact with Caspofungin.

Authors:  Monika Janeczko
Journal:  Pol J Microbiol       Date:  2018

6.  Evolution of generalist resistance to herbicide mixtures reveals a trade-off in resistance management.

Authors:  David Comont; Claudia Lowe; Richard Hull; Laura Crook; Helen L Hicks; Nawaporn Onkokesung; Roland Beffa; Dylan Z Childs; Robert Edwards; Robert P Freckleton; Paul Neve
Journal:  Nat Commun       Date:  2020-06-18       Impact factor: 14.919

Review 7.  Current Screening Methodologies in Drug Discovery for Selected Human Diseases.

Authors:  Olga Maria Lage; María C Ramos; Rita Calisto; Eduarda Almeida; Vitor Vasconcelos; Francisca Vicente
Journal:  Mar Drugs       Date:  2018-08-14       Impact factor: 5.118

8.  Comparison of Joint Effect of Acute and Chronic Toxicity for Combined Assessment of Heavy Metals on Photobacterium sp.NAA-MIE.

Authors:  Nur Adila Adnan; Mohd Izuan Effendi Halmi; Siti Salwa Abd Gani; Uswatun Hasanah Zaidan; Mohd Yunus Abd Shukor
Journal:  Int J Environ Res Public Health       Date:  2021-06-21       Impact factor: 3.390

9.  Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.

Authors:  Shusuke Tomoshige; David A Dik; Masaaki Akabane-Nakata; Chinedu S Madukoma; Jed F Fisher; Joshua D Shrout; Shahriar Mobashery
Journal:  ACS Infect Dis       Date:  2018-05-07       Impact factor: 5.084

10.  Network-principled deep generative models for designing drug combinations as graph sets.

Authors:  Mostafa Karimi; Arman Hasanzadeh; Yang Shen
Journal:  Bioinformatics       Date:  2020-07-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.